Morgan Stanley’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

Morgan Stanley’s Portfolio SLGCW Stock Details SLGCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-182,360	Closed	-$21.9K	–	8124
2023 Q4	$21.9K	Buy	182,360 +91,180	+100%	+$13K	﹤0.01%	6630
2023 Q3	$20.1K	Hold	91,180	–	–	﹤0.01%	6485
2023 Q2	$22.8K	Sell	91,180 -20	-0%	-$7	﹤0.01%	6529
2023 Q1	$23K	Hold	91,200	–	–	﹤0.01%	6571
2022 Q4	$36.5K	Hold	91,200	–	–	﹤0.01%	6425
2022 Q3	$40K	Hold	91,200	–	–	﹤0.01%	6508
2022 Q2	$69K	Hold	91,200	–	–	﹤0.01%	6462
2022 Q1	$184K	Sell	91,200 -400	-0.4%	-$969	﹤0.01%	5974
2021 Q4	$306K	Hold	91,600	–	–	﹤0.01%	5832
2021 Q3	$316K	Buy	+91,600	New	+$282K	﹤0.01%	5750

Other funds holding SLGCW

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Morgan Stanley's SLGCW Position: Q1 2024 in Review

Morgan Stanley sold out of SomaLogic, Inc. Warrant (SLGCW) in Q1 2024, closing a stake of 182,360 shares — an estimated $21.9K sold.

Morgan Stanley first reported a position in SLGCW in Q3 2021 and held it in 10 quarters. The position peaked at $316K in Q3 2021. 4 funds tracked by Wall St. Rank hold SLGCW as of Q1 2024.

Morgan Stanley reported no remaining SomaLogic, Inc. Warrant position as of Q1 2024 after selling out during the quarter.
Morgan Stanley sold 182,360 SomaLogic, Inc. Warrant shares in Q1 2024, an estimated $21.9K.
Morgan Stanley first reported a position in SomaLogic, Inc. Warrant in Q3 2021 and held it in 10 quarters.
Morgan Stanley's SomaLogic, Inc. Warrant position peaked at $316K in Q3 2021.
4 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.